• EE390 Real-World Healthcare Resource Utilization (HCRU) and Economic Burden Among Patients With High-Risk Carcinoma-In-Situ (CIS) Non-Muscle Invasive Bladder Cancer (NMIBC) Using a Large Medicare Dataset

    Jul 1, 2025, 00:00

  • EPH50 Disparities in Access to COPD Medications in Brazil - Impact of Geography and Socioeconomic Factors on Patient Travel Distances

    Jul 1, 2025, 00:00

  • HPR132 Characterizing Post-Pandemic Social Determinants of Health of the Population Testing for COVID-19 in a Nationwide Network in the United States

    Jul 1, 2025, 00:00

  • PCR197 Impact of Cirrhosis on Health-Related Quality of Life and Activity Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada

    Jul 1, 2025, 00:00

  • EE334 Economic Evaluation of Transient Elastography for Significant Fibrosis Detection in Patients With Diabetes Mellitus in Thailand

    Jul 1, 2025, 00:00

  • HTA49 Practical Application of the ICER-developed Clinical Trial Diversity Rating Tool

    Jul 1, 2025, 00:00

  • EE362 Drug Pricing Differentials Across Therapy Areas in EU4, UK, and US

    Jul 1, 2025, 00:00

  • HTA17 Are There Intersections in Evidence Requirements for Health Technology Assessment Agencies across North America, Europe and the Asia-Pacific?

    Jul 1, 2025, 00:00

  • RWD129 type 2 Inflammation and Exacerbator Profiles in COPD Patients: Real-World Data From a Brazilian Specialized Center

    Jul 1, 2025, 00:00

  • HPR164 Pediatric Opioid Prescribing Patterns: Analyzing Trajectories Using Texas PDMP Data in the Context of AAP Guidelines

    Jul 1, 2025, 00:00

  • EE456 The Cost of Complications In Graft Repair For Extremity Arterial Trauma: Real-World Evidence From Linked Hospital Chargemaster And Insurance Claims Databases

    Jul 1, 2025, 00:00

  • EE521 Generalized Cost-Effectiveness Analysis with Dynamic Prevalence for Improving Health Equity Among Rare Diseases

    Jul 1, 2025, 00:00

  • MSR60 From AI to Experts: Understanding Pre-Election Inflation Narratives on Social Media via Sentiment and Topic Analysis

    Jul 1, 2025, 00:00

  • RWD153 A US Real-World Study of Weight Trajectory and Hypothalamic Damage Among Patients With Acquired Hypothalamic Obesity

    Jul 1, 2025, 00:00

  • EPH90 The Potential Clinical Impact of the Moderna Next-Generation COVID-19 mRNA-1283 Vaccine in United States (US) Adults

    Jul 1, 2025, 00:00

  • EE300 Ferric Derisomaltose for the Treatment of Iron Deficiency Anemia: A Real-World Evidence Study

    Jul 1, 2025, 00:00

  • MSR76 A Flexible Dynamic Transmission Model Framework for Evaluating Tuberculosis Treatments: Methodological Challenges and Applications

    Jul 1, 2025, 00:00

  • MSR36 Methods for Handling Non-Proportional Hazards in Economic Modeling

    Jul 1, 2025, 00:00

  • HSD43 Addressing Neighborhood-Level Opioid Data Gaps: Development of an Interactive Dashboard for Prescription Trends and Buprenorphine Access in California

    Jul 1, 2025, 00:00

  • P44 Predicting Overall Survival (OS) from Time to Recurrence (TTR) Using a Copula-Based Patient-Level Surrogacy Model with Parametric Marginal Survival Distributions: Application to Adjuvant Treatment of Patients with Colon Cancer

    Jul 1, 2025, 00:00

  • HPR122 Predicted vs. Actual Drug Spending for Interferon-Free Direct-Acting Antiviral Therapies in Hepatitis C: A Case Study on Drug Spending Forecasts

    Jul 1, 2025, 00:00

  • HPR93 A Targeted Literature Review of Value-Based Agreements (VBAs) for Cell and Gene Therapies in the United States

    Jul 1, 2025, 00:00

  • HTA86 Focus Group Evaluation of Criteria for the Value Assessment of Medication-Adherence Enhancing Interventions (MAEIs)

    Jul 1, 2025, 00:00

  • HSD42 Exploring physicians' Perspectives on the Diagnosis Journey of Rare Diseases in the United States (US): Findings from a Cross Sectional Survey

    Jul 1, 2025, 00:00

  • PCR28 Analysis of the Quality of Life of Patients Undergoing Hip Replacement Surgery Using the SF-36 Questionnaire

    Jul 1, 2025, 00:00

  • HSD4 Aggressive End-of-Life Care among Non-Small Cell Lung Cancer Medicare Patients

    Jul 1, 2025, 00:00

  • HPR111 Assessing Stakeholder Perceptions of Product Portfolio Value Beyond Financial Benefit: Development of a Survey

    Jul 1, 2025, 00:00

  • PCR252 Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Type 2 Diabetes Mellitus

    Jul 1, 2025, 00:00

  • HSD64 Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice

    Jul 1, 2025, 00:00

  • EPH112 Frequency of Gram-Negative Bacteria at the Military Medical Center in Guatemala

    Jul 1, 2025, 00:00

  • PCR173 Psychometric Evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) Instrument in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)

    Jul 1, 2025, 00:00

  • EE488 The Economic Benefit of Biosimilars in North America: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE304 A Cost Minimization and Budget Impact Analysis of an Eculizumab Biosimilar, ABP 959, From the Spanish Healthcare Perspective

    Jul 1, 2025, 00:00

  • HSD83 Identifying Drivers for the Timely Referral of Patients for a Rare Disease Diagnosis: A Cross-Sectional Survey of Physicians in the United States

    Jul 1, 2025, 00:00

  • P16 The Impact of Hallucinations in Synthetic Health Data on Prognostic Machine Learning Models

    Jul 1, 2025, 00:00

  • EE388 Computer-Assisted Fluoroscopic Navigation Is Cost Effective Compared To Robotic-Assisted And Manual Surgery In Total Hip Arthroplasty

    Jul 1, 2025, 00:00

  • RWD30 Assessing and Comparing Inpatient Hospitalization Outcomes for COPD in the United States and OECD Countries

    Jul 1, 2025, 00:00

  • EPH108 Prenatal Exposure to Antiseizure Medication and Risk of Adverse Obstetrical Outcomes: A Population-Based Study

    Jul 1, 2025, 00:00

  • RWD28 Hospitalization for Respiratory Tract Infections Increase the Use of Medical Care and Long-Term Care Services: A Pre-Post Assessment Adopting Difference-in-Differences Analysis on LIFE Study Data

    Jul 1, 2025, 00:00

  • PCR42 Measuring Patient- and Carer-Reported Outcomes Following Genome Sequencing for Rare Disease Diagnosis: A Psychometric Assessment of Outcome Measurement Instruments

    Jul 1, 2025, 00:00

  • RWD135 Retrospective Databases in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research

    Jul 1, 2025, 00:00

  • EE371 A European perspective on Health Resource Utilization (HRU) and Cost outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review

    Jul 1, 2025, 00:00

  • MSR25 NMCP Delayed Time to Hospital Encounter and Reduced Cost compared to OMCP in Patients with Gastroparesis - A Real World Study

    Jul 1, 2025, 00:00

  • HPR35 Disparities in Testing for Mismatch Repair Genes Among Medicare Beneficiaries with Colon Cancer: A Claims-Based Analysis

    Jul 1, 2025, 00:00

  • HSD15 Hypertrophic Scar Severity and Clinical Management in the Real-World Dermatology Setting

    Jul 1, 2025, 00:00

  • PCR132 Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents

    Jul 1, 2025, 00:00

  • PCR141 Estimating the HRQoL Shortfall of Long COVID: Meta Analysis of Cohort Studies Relative to Population Norms

    Jul 1, 2025, 00:00

  • EPH6 Cost and Use of Medical Devices in Incident Early-Onset Myasthenia Gravis Patients in France

    Jul 1, 2025, 00:00

  • EE345 Assessing Health-Related Quality of Life Using the EQ-5D-5L Among Hong Kong Adult Population: The Role of Lifestyle Behaviours

    Jul 1, 2025, 00:00

  • EPH185 Linkage Of Patient Services and Real-world Healthcare Data: A Unique Approach to Gain Insights into Factors that Impact Medication Adherence

    Jul 1, 2025, 00:00

  • RWD31 The Role of Real-World Evidence in Breast Cancer Drug Submissions to NICE: Insights and Challenges

    Jul 1, 2025, 00:00

  • RWD62 Productivity Loss And Indirect Costs Of Heart Failure: Analysis Of The Brazilian Social Security System

    Jul 1, 2025, 00:00

  • MSR156 Examining Factors Contributing to Age of Late-Onset Autoimmune Disease in U.S. Adults Using Hierarchical Clustering Mechanisms

    Jul 1, 2025, 00:00

  • EE383 Pharmacometric-Pharmacoeconomic Modeling and Simulation to Assess Target Product Profile Characteristics in Early Drug Development: Application to Atopic Dermatitis

    Jul 1, 2025, 00:00

  • EE381 Estimating the U.S. Economic Burden of Autoimmune Diseases: A Pilot Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR114 Mapping Health-Related Quality of Life (HRQoL) Measures to Preference Based Measures in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A systematic literature review

    Jul 1, 2025, 00:00

  • PCR83 Treatment Preferences Related to Long-Acting Injectable Buprenorphine Among Patients With Opioid Use Disorder in Australia, Finland, Germany, and Italy

    Jul 1, 2025, 00:00

  • EPH145 Shades of Blue: Investigating Racial, Socioeconomic, and Family Dynamics in Depression Among Teen Girls

    Jul 1, 2025, 00:00

  • PCR217 How Disease Modifying Therapy Utilization In Multiple Sclerosis Is Influenced by Insurance and Out-Of-Pocket Cost in US Adults: A Summary Of Recent Literature

    Jul 1, 2025, 00:00

  • RWD25 Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer

    Jul 1, 2025, 00:00

  • PCR2 Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America

    Jul 1, 2025, 00:00

  • SA3 Methodologic Considerations to Guide Clinician Interpretation and Assessment of Network Meta-Analyses in Psoriasis

    Jul 1, 2025, 00:00

  • HTA34 Assessability of Single-Arm Studies (SAT) Under Joint Clinical Assessment (JCA): Whether Drugs Assessed With SAT in the Last Years Would Fit Under the New EU HTA Framework?

    Jul 1, 2025, 00:00

  • HTA52 Too Many PICOS for Joint Clinical Assessments (JCA)? How To Adapt The Systematic Literature Reviews for Achieving Desired Outcomes

    Jul 1, 2025, 00:00

  • RWD143 Advancing Breast Cancer Research in Japan Using EHR-Derived Real-World Data

    Jul 1, 2025, 00:00

  • RWD125 Retrospective Real-World Study Assessing Treatment Patterns of Adult Patients with Moderate-to-Severe Psoriasis in the United States Initiating Advanced Therapies and Their Dispositions

    Jul 1, 2025, 00:00

  • MSR57 Extended MAIC to Validate Results in Cases of Poor Population Overlap: An Application to Compare Prophylactic Treatments in Pediatric Patients With Hemophilia A

    Jul 1, 2025, 00:00

  • HTA95 Mind The Gap: Delays Between Vaccine Licensure And NITAG Recommendation In The US Versus Europe

    Jul 1, 2025, 00:00

  • EPH39 Estimating the Prevalence of Chronic Conditions in Population Health Management

    Jul 1, 2025, 00:00

  • PCR174 Facilitating Effective Implementation of Qualitative in Trial Interviews

    Jul 1, 2025, 00:00

  • RWD112 Real-World Utilization of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults

    Jul 1, 2025, 00:00

  • EE284 Is Every Peripheral Catheter the Same? Economic Burden and Budget Impact of Accidents and Phlebitis in Peripheral Venous Access According to Catheter Material and Safety Device

    Jul 1, 2025, 00:00

  • EE384 Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study

    Jul 1, 2025, 00:00

  • EE518 Impact of Information Technology Enhancement for Human Papillomavirus Vaccination: Time and Cost Savings

    Jul 1, 2025, 00:00

  • HPR29 Evaluating Therapeutic Alternative Selection in Medicare's Initial Drug Price Negotiation Explanations

    Jul 1, 2025, 00:00

  • P13 Leveraging Real-World Data and NLP to Identify At Risk Metabolic Dysfunction Associated Steatohepatitis in the General Population

    Jul 1, 2025, 00:00

  • Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR259 Information-Seeking Behavior of the Hungarian Population Regarding Breast Cancer: A Digital Epidemiological Study using Google TrendsTM

    Jul 1, 2025, 00:00

  • EPH106 Trend of Cervical Cancer Mortality in Colombia From 1998 to 2022

    Jul 1, 2025, 00:00

  • HSD59 Disparities in Tardive Dyskinesia Diagnosis and Treatment Among the US Medicare Population

    Jul 1, 2025, 00:00

  • HPR136 From Data to Decisions: The Role of Real-World Evidence in Recent Multiple Myeloma Drug Approvals in the US and EU

    Jul 1, 2025, 00:00

  • P58 A Bayesian State-Transition Model-Based Approach to Estimate Transition Rates From Aggregated Survival Data

    Jul 1, 2025, 00:00

  • HPR79 Unlocking AI's Potential in Pricing and Reimbursement: Insights Across Global Healthcare Archetypes

    Jul 1, 2025, 00:00

  • EPH173 Baseline Risk of Hospitalization and Mortality in High-Risk Subgroups of a Nirmatrelvir/Ritonavir Treatment-Eligible Population With Mild-to-Moderate COVID-19 in the United States: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR257 Real-World Evidence on Health-Related Quality of Life in Older Women With Advanced Breast Cancer Treated With CDK 4/6 Inhibitors

    Jul 1, 2025, 00:00

  • PCR171 Examining Health Behaviour of Inviduals Diagnosed With Polycystic Ovary Syndrome

    Jul 1, 2025, 00:00

  • PT30 Evolving Trends in Racial and Ethnic Disparities in Syphilis Prevalence Among People Who are Pregnant in The United States from 2016 To 2023

    Jul 1, 2025, 00:00

  • HTA10 Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency

    Jul 1, 2025, 00:00

  • EE417 Budget Impact Analysis of Venetoclax Combination Therapies for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Aged 75 Years or Older, or Who Have Comorbidities That Preclude Use of Intensive Induction Chemoth ...

    Jul 1, 2025, 00:00

  • RWD46 Operational Definitions in Practi Finding and Evaluating Algorithms for Identifying Patients with Cervical and Uterine Cancer for Real World Data Studies

    Jul 1, 2025, 00:00

  • MSR63 Extraction of Pulmonary Function Test Results from Unstructured Clinical Notes using a Retrieval-Augmented Generation Approach on a Major Cloud Platform

    Jul 1, 2025, 00:00

  • PT33 Reliability and Validity of EuroQol-5 Dimensions-5 Levels in Patients with Hematologic Malignancies: A Cross-Sectional Study

    Jul 1, 2025, 00:00

  • EE249 Quantifying the Financial Burden of HbA1c Levels: A Retrospective Single-Center Analysis of Healthcare Costs in South Korean Diabetes Patients

    Jul 1, 2025, 00:00

  • HTA21 Integrating Cancer Trials Into Value-Based Care: The ‘Let Me Trial’ Model in Brazil

    Jul 1, 2025, 00:00

  • EPH120 Clinical Characteristics and Healthcare Resource Utilization Among Patients Initiating Semaglutide 2.4mg Versus Those Not Treated With Anti-Obesity Medications

    Jul 1, 2025, 00:00

  • HPR144 Factors Delaying the Public Listing of New Drugs in Canada

    Jul 1, 2025, 00:00

  • EE266 Exploring the Broader Societal Value of Pembrolizumab in Triple-Negative Breast Cancer and Cervical Cancer in Brazil

    Jul 1, 2025, 00:00

  • PCR43 Challenges and Opportunities for the Use of Patient Experience Data in Gene Therapy Trials

    Jul 1, 2025, 00:00

  • PCR206 Incorporating Best-Worst Scaling into Attribute Selection for Stated Preference Research: A Study Based on Preference for Choosing Antidepressants

    Jul 1, 2025, 00:00

  • CO84 Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A retrospective Cohort Study using Electronic Health Record Data

    Jul 1, 2025, 00:00

  • MSR8 Is Bayesian Statistics an Emerging Way for Extrapolating Survival in Cost-Effectiveness Analysis: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR11 Diversity, Equity, and Inclusion in Gene and Cell Therapies Clinical Trials

    Jul 1, 2025, 00:00

  • MSR83 Early Detection of CHAPLE Disease in Pediatric Protein-Losing Enteropathy: A Feasibility Study

    Jul 1, 2025, 00:00

  • HTA71 The Prevalence of Fractional-Polynomial Network Meta-analyses (fpNMAs) in Supporting Reimbursement Recommendations by Canada's Drug Agency (CDA-AMC)

    Jul 1, 2025, 00:00

  • EPH180 Trends of Mortality by Ulcer Decubitus in Colombia, 1998 - 2022

    Jul 1, 2025, 00:00

  • CO36 Impact of Procedure Wait Times on One-Year Health Outcomes in Patients With Degenerative Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair

    Jul 1, 2025, 00:00

  • HTA66 Cost-Effectiveness of Intravenous Ferric Carboxy Maltose Versus Iron Sucrose to Treat Anemia in Pregnancy in Indian Context

    Jul 1, 2025, 00:00

  • HPR130 Patient Journey Mapping for Common Illness Care Services at Community Pharmacies

    Jul 1, 2025, 00:00

  • PCR158 Enhancing Patient Engagement in Pharmacist-Provided Medication Therapy Management for Chronic Conditions

    Jul 1, 2025, 00:00

  • PCR165 Qualitative Interviews to Characterize Disease and Treatment Burden at Baseline in Adult and Pediatric Patients Participating in a Pivotal Phase 3 Trial of DTX401 for the Treatment of Glycogen Storage Disease Type Ia

    Jul 1, 2025, 00:00

  • HSD18 Variation in Recombinant Zoster Vaccine Uptake and Completion by Utilization of Office-Based Vaccination

    Jul 1, 2025, 00:00

  • HPR166 Improving the Healthcare System Through Health Technology Assessment: A Case Study of Nepal

    Jul 1, 2025, 00:00

  • MSR32 Dual Inhibitor Identification for Mutated IDH1/2 To Reduce D-2-Hydroxyglutarate in Glioblastoma

    Jul 1, 2025, 00:00

  • PCR135 Disparities in COVID-19 Vaccination Uptake by Social Vulnerability Index: A US nationwide study

    Jul 1, 2025, 00:00

  • MSR145 Do Framing and Attribute Number Influence Choice Consistency in a Preference-Based Value Assessment of Equity and Efficiency?

    Jul 1, 2025, 00:00

  • PCR58 Mapping the HAQ-DI to the EQ-5D-5L and SF-6Dv2 Among Chinese Patients With Gout

    Jul 1, 2025, 00:00

  • HPR141 Analysis of Patient Pathway on In Vitro Fertilization Treatment in Hungary

    Jul 1, 2025, 00:00

  • HTA3 The Institute for Clinical and Economic Review and Joint Clinical Assessment: Insights for Manufacturers in an Evolving Health Technology Assessment Landscape

    Jul 1, 2025, 00:00

  • EE336 A Conceptual Epidemiological and Economic Model to Predict Obesity in Low- and Middle-Income Countries: A Meta-Synthesis

    Jul 1, 2025, 00:00

  • HPR145 Medicare Spending on Orphan Drugs With Single and Multiple Rare Disease Indications

    Jul 1, 2025, 00:00

  • EE375 Real-World Adherence, Healthcare Resource Utilization, And Costs Among Patients With Schizophrenia Utilizing Once-Monthly, Once-Every-Three-Months, And Once-Every-Six-Months Paliperidone Palmitate in the United States

    Jul 1, 2025, 00:00

  • PCR155 Real-World Treatment Patterns and Clinical Characteristics Among Patients With Crohn’s Disease Receiving First- and Second-Line Biologic Treatments in The United States

    Jul 1, 2025, 00:00

  • EE226 Household Costs and Other Societal Impacts for Individuals With Duchenne Muscular Dystrophy Stratified by Upper Limb Impairment: Results From a Caregiver Survey

    Jul 1, 2025, 00:00

  • MSR96 GenAI for Critical Appraisal of Evidence for Systematic Literature Reviews (SLRs): A Face-Off between GenAI and Human Reviewers

    Jul 1, 2025, 00:00

  • EE418 Cost-effectiveness of Esketamine versus Real-world Treatments for Patients with Treatment-resistant Depression: A Multi-armed Modelling Study

    Jul 1, 2025, 00:00

  • MSR1 Predictive Modeling for Designing a Personalized Statin Therapy: Optimizing Treatment Efficacy in Cardiovascular Disease Prevention

    Jul 1, 2025, 00:00

  • PCR229 Increasing Clinical Trial Participation in Native Hawaiian, Pacific Islander, and Asian Communities

    Jul 1, 2025, 00:00

  • HPR108 Trends in the Prescribing and Dispensing of GLP-1 Anti-Obesity Medications Among U.S. Adults with Cardiovascular Disease and Overweight or Obesity, 2021-2024

    Jul 1, 2025, 00:00

  • EPH179 Associations Between Post-Diagnostic Statin Use, Cholesterol Levels, and Mortality Risk Among American Breast Cancer Patients: Insights from the National Health and Nutrition (NHANES) Survey

    Jul 1, 2025, 00:00

  • MSR101 Evaluating Pain Scores and Detecting NSCLC Using Named Entity Recognition and Agentic AI in Clinical Texts

    Jul 1, 2025, 00:00

  • PCR161 Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EPH67 Association between Polypharmacy and Cognitive Limitations among Adults with Depression in the United States

    Jul 1, 2025, 00:00

  • HSD32 Innovative Strategy for Resistant Depression and Suicidal Ideation: HEOR Analysis From the Perspective of BRAZIL / LATAM / LMIC

    Jul 1, 2025, 00:00

  • SA12 Incidence, Prevalence, and Risk Factors of Giant Cell Arteritis: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • R Packages for Matching-Adjusted Indirect Comparison: Differences in Usability and Identical Results From Reuse of Prior Code

    Jul 1, 2025, 00:00

  • Economic Evaluation Results Are Substantially Affected by Parameter Input Correlation

    Jul 1, 2025, 00:00

  • EPH66 Antidiabetic Medication Uses Among Pregnant Women: Real-World Prescription Pattern in South Korea

    Jul 1, 2025, 00:00

  • EE203 Comparing Ex-Vivo and In-Vivo Administration in CRISPR-Based Gene Therapies for Beta-Thalassemia: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • HSD95 Development of a Tool for Population Health Risk Stratification in Primary Care Through Consensus-Seeking Techniques

    Jul 1, 2025, 00:00

  • RWD168 Burden of Illness in CIDP: Results of a Multinational Real-World Survey

    Jul 1, 2025, 00:00

  • MT25 Modeling Challenges and Critiques in Economic Evaluations of Medical Devices: A Review of NICE Medical Technologies Guidance

    Jul 1, 2025, 00:00

  • EE498 Acute Care Visits and Readmissions Among Medicare Beneficiaries with Heart Failure with Preserved Ejection Fraction (HFpEF) by Obesity Classes

    Jul 1, 2025, 00:00

  • RWD33 Trends in GLP-1 Utilization for Diabetes and Obesity in the US: A Retrospective Analysis (2017-2023)

    Jul 1, 2025, 00:00

  • EPH100 Acute eGFR Dip with SGLT2 Inhibitors vs. Other Antihyperglycemic Medications Among People with HIV

    Jul 1, 2025, 00:00

  • RWD113 Impact of NGS Testing Timing on Real-World Treatment Patterns and Clinical Outcomes in Colorectal Cancer: A Retrospective Observational Study

    Jul 1, 2025, 00:00

  • PCR7 Mapping the GIS to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Gout

    Jul 1, 2025, 00:00

  • CO4 Systematic Evaluation of Bone Health Dynamics Associated With GLP-1 Receptor Agonists in Type 2 Diabetes Patients: Fracture Risk and Osteoporotic Complications

    Jul 1, 2025, 00:00

  • EE486 PICC Line (PICC) or Central Inserted Venous Catheter (CICC ) in Cancer Patients: Comparative Effectiveness and Cost-Effectiveness Analysis in Brasil/LATAM/LMIC

    Jul 1, 2025, 00:00

  • MSR67 Prognostic Model for Overall Survival in Colorectal Cancer Patients in the US: A Real World Data Study

    Jul 1, 2025, 00:00

  • CO74 Survival Outcomes of Stage IV Endometrial Cancer Patients with Lung Metastasis: A SEER-Based Cohort Study

    Jul 1, 2025, 00:00

  • HTA5 Health Technology Assessment Evidence Requirements for Companion Diagnostics Associated with Targeted Therapies in Oncology

    Jul 1, 2025, 00:00

  • HSD74 Comparison of Machine Learning Models To Predict US Adolescent Mentalhealth Trends

    Jul 1, 2025, 00:00

  • EE379 Economic and Environmental Impact of Decentralized Cancer Care (DCC) in Oncology: An Innovative Experience in the French Alps

    Jul 1, 2025, 00:00

  • EE520 Evaluating the Budgetary Impact of the Wearable Cardioverter Defibrillator Service for Patients at Risk of Sudden Cardiac Death in the United Kingdom

    Jul 1, 2025, 00:00

  • EPH58 Evaluating the Cost-Effectiveness of Wastewater-Based Disease Surveillance

    Jul 1, 2025, 00:00

  • EE206 Cost-Effectiveness of a Hypothetical Dementia Prevention Treatment for Stroke Survivors

    Jul 1, 2025, 00:00

  • MT5 Real-Time Technology Adoption: Assessing Early Real-World Trends in Renal Denervation Therapy Following Initial Device Approval

    Jul 1, 2025, 00:00

  • P64 Impact of JCA and Project Orbis on the European Revenue Potential of an Oncology Product

    Jul 1, 2025, 00:00

  • EE274 Epidemiological Analysis and Patient Profile of Lung Cancer in the Brazilian Public Health System: A Real-World Data Study

    Jul 1, 2025, 00:00

  • HSD5 Assessment of Willingness and Influencing Factors for COVID-19 Booster Vaccination Among Residents of Hong Kong in the Post-Pandemic Context

    Jul 1, 2025, 00:00

  • EE457 Real-World Study Evaluating Drug Tolerability and Health Care Resource Use (HCRU) With Acalabrutinib vs. Ibrutinib in Treatment-Naïve Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

    Jul 1, 2025, 00:00

  • PCR195 Treatment Preferences in Adults with Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines: Insights from CHOICE-CSU 2 Study

    Jul 1, 2025, 00:00

  • MSR84 Data Extraction in Literature Reviews Using an Artificial Intelligence Model: Prompt Development and Testing

    Jul 1, 2025, 00:00

  • HTA87 Study on Online Tools of Pharmacoeconomic Model Construction and Value Communication

    Jul 1, 2025, 00:00

  • MSR13 TransportHealth: A Novel, Flexible, Open-Source R Package for Transportability and Generalizability Analysis

    Jul 1, 2025, 00:00

  • HTA6 Real-World Evidence (RWE) in Health Technology Assessment (HTA): Global Guidelines on the Use of RWE in Evidence Generation for HTA Evaluation

    Jul 1, 2025, 00:00

  • MSR91 Reliability of Insurance Claims to Categorize Obesity in Patients with Obstructive Sleep Apnea

    Jul 1, 2025, 00:00

  • HSD101 Treatment Patterns in the Management of Alopecia Areata in a Colombian HMO During 2015-2023: A Real-World Data Study

    Jul 1, 2025, 00:00

  • EE205 Impact of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments: Brazilian Model

    Jul 1, 2025, 00:00

  • HPR160 Relationships Between ICER Clinical Evidence Ratings and FDA Approval Decisions

    Jul 1, 2025, 00:00

  • HSD28 Geographic Variation in Lower Limb Prosthesis Prescription Disparities Between White and Black Veterans: A Retrospective Cohort Analysis (2010 - 2022)

    Jul 1, 2025, 00:00

  • CO96 Development of a Patient Reported Outcome Measure for GastroIntestinal Recoveryafter Surgery (PRO-diGI)

    Jul 1, 2025, 00:00

  • MT30 Clinical and Economic Outcomes of Ultrasonic Energy Devices Used in Patients Treated With Sleeve Gastrectomy

    Jul 1, 2025, 00:00

  • EPH161 A German Claims Database Analysis of Epidemiology, Treatment Patterns, and Healthcare Resource Utilization of Patients with Primary Biliary Cholangitis (PBC)

    Jul 1, 2025, 00:00

  • HSD97 Market Access as Defined by Professionals with Market Access Backgrounds - Scoping Review

    Jul 1, 2025, 00:00

  • EE261 Cost-Effectiveness of Tumor-Treating Fields in Combination With Temozolomide for Glioblastoma Patients: An Italian Healthcare System Perspective

    Jul 1, 2025, 00:00

  • CO2 Differential Effect of Transdiagnostic Cognitive-Behaviour Therapy on Health-Related Quality of Life According to the Number of Anxiety Comorbidities

    Jul 1, 2025, 00:00

  • MT13 Challenges of Pre-Market Clinical Investigations of Medical Devices: A Multi-Stakeholder Perspective

    Jul 1, 2025, 00:00

  • MSR150 Validity and Accuracy of Asthma-Related ICD-10 Diagnosis Codes in United States Real-World Administrative Database

    Jul 1, 2025, 00:00

  • SA5 Systematic Literature Review of Unmet Needs and Burden of Disease in Generalized Anxiety Disorder (GAD)

    Jul 1, 2025, 00:00

  • RWD146 The Cost Burden of Infertility Therapy for Women with a History of Hysteroscopic Adhesiolysis Compared to Those with Other or no Previous Intrauterine Surgery

    Jul 1, 2025, 00:00

  • First-Line Alectinib, Brigatinib, and Lorlatinib for Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • EE221 How to Mitigate "Carer QALY Trap” when Including Caregiver QOL in Cost-Effectiveness Analysis: A Model Simulation Using Lecanemab in Japanese Patients with Alzheimer's Disease

    Jul 1, 2025, 00:00

  • EE213 Cost-Utility analysis of Dinutuximab Beta in Treating High-Risk Neuroblastoma: A Partitioned Survival Model Using R programming Language

    Jul 1, 2025, 00:00

  • Author Reply

    Jul 1, 2025, 00:00

  • CO60 Relationship between Genetic Polymorphisms and Clinical Parameters in Mexican Postmenopausal Women: A Study on Cardiovascular Health

    Jul 1, 2025, 00:00

  • PCR168 Assessing the Validity of the SF-36 Health Survey Among Chinese Individuals with Spinal Cord Injuries

    Jul 1, 2025, 00:00

  • PCR72 Optimizing Communication Strategies for COPD Management: Effectiveness of Educational Video and Pamphlet Interventions

    Jul 1, 2025, 00:00

  • HTA98 Mapping of Health Technology Assessment in China: Progress and Challenges from a Nationwide Repeated Cross-Sectional Survey

    Jul 1, 2025, 00:00

  • RWD140 Validity of Diagnostic Codes to Identify Metastatic Prostate Cancer in Medicare Claims Database

    Jul 1, 2025, 00:00

  • EE395 The Annual Economic Burden of RSV in High-Risk US Adults Aged 18-59: A Modeling Study

    Jul 1, 2025, 00:00

  • HPR95 Participation in a Patient Support Program is Associated With Improved Access to Efgartigimod Treatment for Generalized Myasthenia Gravis in Patients Facing Social Determinants of Health (SDOH) Challenges

    Jul 1, 2025, 00:00

  • MT19 Exploring Patient Perceptions on an eHealth Application and Health Management Module in Hong Kong: A Qualitative Investigation

    Jul 1, 2025, 00:00

  • HTA43 Assessing the Added Value of Fixed-Dose Combinations in Non-Communicable Diseases: A Comparative HTA Analysis Across Canada, Scotland, France, and Germany (2014-2024)

    Jul 1, 2025, 00:00

  • PCR68 Perceived Health Status among Patients with Norovirus and Acute Gastroenteritis

    Jul 1, 2025, 00:00

  • MSR113 Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population

    Jul 1, 2025, 00:00

  • HTA72 Payer Perspectives on ICER Evidence Reports: InsightsInto Utility for Coverage and Formulary Decision-Making

    Jul 1, 2025, 00:00

  • EE401 Return on Investment and Waste Considerations for the Implementation of Rechargeable Batteries in Video Laryngoscopes

    Jul 1, 2025, 00:00

  • CO92 Understanding Predictors of Early-Onset Colorectal Cancer in Personal Health Data with Machine Learning

    Jul 1, 2025, 00:00

  • PCR121 Elephant in the Room: Gap Between the Awareness and Need for Psycho-Social Support for Czech Lymphoma Patients as Captured Through the Analyzes of Social and Traditional Media

    Jul 1, 2025, 00:00

  • EE257 Cost-Effectiveness of Sotagliflozin for Patients With Type 1 Diabetes and Chronic Kidney Disease, With and Without Dynamic Pricing

    Jul 1, 2025, 00:00

  • PCR113 One Size Doesn’t Fit All: Learnings from a Pilot Survey Assessing Preferences for Improvement vs Worsening of Healthcare Professionals

    Jul 1, 2025, 00:00

  • HPR78 Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis

    Jul 1, 2025, 00:00

  • MSR49 The Quantification of Efficacy and Accuracy for Screening and Data Extraction in Perinatal Mood and Anxiety Disorders Studies: A Comparative Analysis of Traditional vs. GenAI-Powered Approaches

    Jul 1, 2025, 00:00

  • HPR121 What Drug Characteristics Explain the Wide range of Manufacturer Rebates?

    Jul 1, 2025, 00:00

  • HPR167 Understanding How Formulary Pricing Models Shape Medication Accessibility and Financial Burden for Aging Populations

    Jul 1, 2025, 00:00

  • PCR96 Sociodemographic Variations in Perceived Social Support Among Adults with Depression in the United States: Results From the National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • PCR225 Psychometric Validation and Meaningful Within-Patient Change of the FAACT-5IASS in Patients With Cancer Cachexia

    Jul 1, 2025, 00:00

  • MT33 A Systematic Literature Review and Meta-Analysis of Clinical Outcomes Across Five Malignant Procedures for Robotic-Assisted Surgery with the Da Vinci Single Port Surgical System

    Jul 1, 2025, 00:00

  • HPR7 Software as a Medical Devi Current Regulations in North America and Europe

    Jul 1, 2025, 00:00

  • MT31 Adoption of a Drug Adherence-Enhancing Application To Achieve Optimal Medication Adherence and Blood Pressure Control Among Hypertensive Patients: A Randomized Controlled Trial

    Jul 1, 2025, 00:00

  • P21 Evaluating the Performance of Claude 3.5 Sonnet in Data Extraction Automation for Systematic Literature Reviews (SLRs)

    Jul 1, 2025, 00:00

  • EE315 Real-World Disease Management Costs for U.S. Patients With Muscle Invasive Bladder Cancer (MIBC) Following Radical Cystectomy (RC) in Contemporary Practice

    Jul 1, 2025, 00:00

  • HPR151 Comparing the Differences in MentalHealthcare Coverage Between US Public and Private Healthcare Insurers

    Jul 1, 2025, 00:00

  • HPR18 Real-world Impact of the United States Preventive Services Task Force (USPSTF) Guidelines on HIV-1 Pre-Exposure Prophylaxis (PrEP) Ancillary Service Cost Sharing: Segmented Change Pre- and Post-Milestone USPSTF Timepoints

    Jul 1, 2025, 00:00

  • EPH79 Assessing Adolescent Mental Health Prevalence and Incidence Pre- and Post-COVID-19 Among Texas Medicaid Recipients

    Jul 1, 2025, 00:00

  • MSR37 Improve Analyst Accuracy in Systematic Literature Reviews Using Reliant Tabular and LLM-Based Relevance Scoring

    Jul 1, 2025, 00:00

  • RWD43 Public Awareness and Perspectives on Respiratory Syncytial Virus Vaccination in Hong Kong: A Comprehensive Population-Based Study

    Jul 1, 2025, 00:00

  • PCR120 Experiences of Hungarian Mothers About Breastfeeding Support From Health Visitors

    Jul 1, 2025, 00:00

  • PCR105 The Impact of Caring for Juvenile Idiopathic Arthritis Patients on Caregivers’ Quality of Life

    Jul 1, 2025, 00:00

  • RWD159 Burden of Illness in US Patients With Liver Cancer and Kidney Disease: A Real-World Claims Analysis

    Jul 1, 2025, 00:00

  • PCR175 Are Cancer Trials Aligned With FDA's 2021 Guidance on Patient-Reported Outcomes?

    Jul 1, 2025, 00:00

  • OP2 A Descriptive Analysis of Key Findings From the 2024-2025 ISPOR Student Interest Survey

    Jul 1, 2025, 00:00

  • EPH55 Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil

    Jul 1, 2025, 00:00

  • MSR59 An Open-Source R-Shiny Application Designed to Perform Frequentist and Bayesian Mixed Model Repeated Measures (MMRM)

    Jul 1, 2025, 00:00

  • EE342 Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study

    Jul 1, 2025, 00:00

  • EE501 Cost-Effectiveness Analysis of Screening for Cervical Lesion and Diagnosis and Treatment of Cervical Cancer In Nigeria

    Jul 1, 2025, 00:00

  • HTA45 Analysis of NICE Assessments for Orphan Treatments and Key Drivers for Decision-Making

    Jul 1, 2025, 00:00

  • RWD59 Uptake of national guidance for prescribing of SGLT-2 inhibitors for type 2 diabetes in the UK

    Jul 1, 2025, 00:00

  • HPR159 Problems in the Drug System Related to Household Medicine Classification Criteria: A Gap Analysis for Modernizing the Criteria

    Jul 1, 2025, 00:00

  • CO30 The Relationship Between Progression-Free Survival and Overall Survival in Relapsed/Refractory Multiple Myeloma: A Meta-Regression of Clinical Trial Data

    Jul 1, 2025, 00:00

  • RWD17 Evolving Real-world Trends in Biomarker Testing for Bladder Cancer: A Comprehensive Retrospective Analysis from the US Community Oncology Setting (2015-2024)

    Jul 1, 2025, 00:00

  • HPR60 What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus

    Jul 1, 2025, 00:00

  • RWD63 Real-World Patient Persistence and Adheren A Comparison Of Long Acting Injectables and Oral Antipsychotics Used For The Treatment Of Schizophrenia in a Canadian Adult population

    Jul 1, 2025, 00:00

  • CO72 Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Experienced Patients with T2D

    Jul 1, 2025, 00:00

  • EPH166 Anemia-Related Survival of Patients with Myelofibrosis: A Retrospective Real-World Study

    Jul 1, 2025, 00:00

  • MSR134 A Web-Based Application To Automate the Development of State-Transition Models in Oncology Using Published Survival Curves and Bayesian Calibration

    Jul 1, 2025, 00:00

  • HSD8 A Case-Study on the Implementation of the Population Health Agreement for Inclisiran in England

    Jul 1, 2025, 00:00

  • MSR139 Application of Generative Artificial Intelligence for Extracting Structured Data from Unstructured Bladder Cancer Pathology Reports

    Jul 1, 2025, 00:00

  • HPR120 Study on the Impact of the National Drug Price Negotiation Policy on the Affordability of Innovative Drugs in China

    Jul 1, 2025, 00:00

  • PCR249 Impact of Cardiovascular, Renal and Metabolic Comorbidities on Activity and Health-Related Quality of Life in Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada

    Jul 1, 2025, 00:00

  • P47 Patient Preferences on Understanding Medical Tests and Monitoring Equipment in Hospitalized Care

    Jul 1, 2025, 00:00

  • P28 The Use of Artificial Intelligence in the Development of Economic Models

    Jul 1, 2025, 00:00

  • PCR240 A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia

    Jul 1, 2025, 00:00

  • EPH98 Prevalence of Diabetes and Its Impact on Hospitalization among Patients with Cancer: A Population-Based Study in the U.S

    Jul 1, 2025, 00:00

  • EPH125 Validation of ICD Code-Based Identification of Myocarditis Among mRNA COVID Vaccine Immunized Patients and COVID-Infected Patients

    Jul 1, 2025, 00:00

  • PT38 Assessing the Impact of Digital Ecosystem Engagement on Outcomes in Sickle Cell Disease (SCD) Patients

    Jul 1, 2025, 00:00

  • EE220 Impact of Post-Discharge Rifaximin Use Following an Overt Hepatic Encephalopathy (OHE) Hospitalization on Annual Rates of OHE Rehospitalization in the United States

    Jul 1, 2025, 00:00

  • HSD3 Gaps In Screening Among Medicare Patients With A Ruptured Abdominal Aortic Aneurysm

    Jul 1, 2025, 00:00

  • MSR110 From Manual to Machine: A Deep Dive into AI-Powered Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • HSD58 Potential Added Clinical Value of Polygenic Risk Scores in Risk Assessment of Atherosclerotic Cardiovascular Disease

    Jul 1, 2025, 00:00

  • PCR49 Exploring the Link Between Self-Efficacy and Medication Adheren Psychometric Evaluation of the Traditional Chinese Beliefs About Medicines Questionnaire-Specific in Adults With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • HSD21 A Qualitative Assessment of Emergency Physician Perceptions and Experiences with Acute Pain Management

    Jul 1, 2025, 00:00

  • EE512 How HTA Should Consider the Global Value of Health Products to Support Public Decision?

    Jul 1, 2025, 00:00

  • P34 Are Pediatric Trials Including More Patient-Centered Outcomes?

    Jul 1, 2025, 00:00

  • MSR149 An AI-Powered RAG Based Framework for Data Extractions in Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • P51 How Can We Make Innovative Payment and Pricing Schemes Work? Findings of the European Union Research Project HI-PRIX

    Jul 1, 2025, 00:00

  • HSD73 Real-World Primary Care Data on Menopause: Insights into Diagnoses, Treatment Patterns, and Care Gaps

    Jul 1, 2025, 00:00

  • PT22 Payer Archetypes and Decision-Making in the United States (US): A framework for Generalised Cost-Effectiveness Analysis (GCEA) Value Elements to Optimize Patient Access and Equity

    Jul 1, 2025, 00:00

  • RWD94 Challenges in Projecting Treatment Journeys for ALK-mutated NSCLC: Addressing Uncertainty in PPS and Immature Overall Survival Data

    Jul 1, 2025, 00:00

  • EPH41 Use of Artificial Intelligence for Rapid Epidemiology Reviews With Pooled Prevalence and Incidence Estimates

    Jul 1, 2025, 00:00

  • MSR15 Leveraging AI/Technology in Survey Design, Deployment, and Analysis

    Jul 1, 2025, 00:00

  • P61 Implementation of the IRA: Evolving Perspectives from US Stakeholders

    Jul 1, 2025, 00:00

  • HSD76 A Real-World Study on Healthcare Resource Utilisation and Patient Care for People With Transthyretin Amyloid Polyneuropathy

    Jul 1, 2025, 00:00

  • PCR41 Exploring the Landscape of Patient-Reported Outcomes in PCOS Clinical Trials

    Jul 1, 2025, 00:00

  • MT9 Assessment of Artificial Intelligence-Enabled Health Technologies: Our Initial Experience at Canada's Drug Agency

    Jul 1, 2025, 00:00

  • PCR159 Measurement of Short-Term Functional Outcome Using Modified Rankin Scale in Patients With Acute Ischaemic Stroke

    Jul 1, 2025, 00:00

  • EE439 Double Immune Checkpoint Inhibition as First-Line Treatment for BRAF-Mutant Advanced Melanoma: A Cost-Effectiveness Analysis from the Brazilian Private Healthcare System Perspective

    Jul 1, 2025, 00:00

  • HSD91 Development of an Online Patient Decision Aid and Culturally Conscious Toolkit for Inflammatory Bowel Disease

    Jul 1, 2025, 00:00

  • MT11 How Does it Stack Up? User Comparison of the Ambu aScope 5 Uretero Against Reusable Ureteroscope Platforms

    Jul 1, 2025, 00:00

  • PT20 Estimating the Cost at which GLP-1 RAs Would become Cost-Effective for Multimorbid Type 2 Diabetes Patients in Canada

    Jul 1, 2025, 00:00

  • EE269 Health Economic Assessment of High-Protein Diet Using High-Protein ONS for Weight Maintenance Following Weight Loss Using GLP-1RAs

    Jul 1, 2025, 00:00

  • HPR58 Exploring Contemporary Variability in PDMP Budgets and Data Sharing Across the United States

    Jul 1, 2025, 00:00

  • EE295 Modeling the Potential Health Benefits of Improving Nutrition in Australian Indigenous Populations

    Jul 1, 2025, 00:00

  • PT8 Time-Driven Activity-Based Costing in Healthcare: Should We Adjust for Inflation or Reapply the Method?

    Jul 1, 2025, 00:00

  • EE212 Healthcare Resource Utilization Associated With Myotonic Dystrophy Type 1 With Complex Care Needs: Results From the Real-World IMPaCT Study

    Jul 1, 2025, 00:00

  • PCR26 Defining Unmet Need to Optimize Management of Adults and Adolescents With Psoriasis: Development of a Global Multistakeholder Survey

    Jul 1, 2025, 00:00

  • HSD89 Unmet Need in Non-Metastatic Oral Cavity Cancer in the United States: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HTA67 Developing a Selection Framework for Comparator in HTA-Based Inclusion in China's National Reimbursement Drug List

    Jul 1, 2025, 00:00

  • EE415 Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States

    Jul 1, 2025, 00:00

  • EPH184 Metformin Exposure and Survival in Glioblastoma: A Large Population Study

    Jul 1, 2025, 00:00

  • PCR182 Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients With C1 Inhibitor Deficiency (Type I/II) and =8 Attacks Per Month

    Jul 1, 2025, 00:00

  • HPR38 Review of NICE, PBAC, and CDA HTA Outcomes For Oncology Drugs Approved by the FDA Through Project Orbis (2022-2023)

    Jul 1, 2025, 00:00

  • HTA91 Advancing Equitable Access to Cystic Fibrosis Treatment in Brazil: Strategies for Implementing National Clinical Guidelines

    Jul 1, 2025, 00:00

  • CO3 Assessing Time to Metastatic Disease as a Proxy for Overall Survival in a Real-World Pan-Tumor Cohort

    Jul 1, 2025, 00:00

  • EE207 Healthcare Utilization and Costs in New Users of Once-Weekly GLP-1 Receptor Agonists vs Other Glucose-Lowering Therapies Among Medicare Beneficiaries With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease

    Jul 1, 2025, 00:00

  • P17 Health Inequality Aversion in the United States and Americans' Views on Health Inequality

    Jul 1, 2025, 00:00

  • EPH169 Contemporary Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of German Claims Data

    Jul 1, 2025, 00:00

  • HTA47 Modeling the Path to Cure: How (NEO)Adjuvant Drug Therapies are Evaluated in Health Technology Assessment (HTA)

    Jul 1, 2025, 00:00

  • EE450 National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States

    Jul 1, 2025, 00:00

  • PCR162 Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil

    Jul 1, 2025, 00:00

  • EPH46 Evaluation of Epidemiological Disease Burden of Endometriosis Based on Routinely Collected Health Data Between 2010 and 2019

    Jul 1, 2025, 00:00

  • EPH109 Association of Cognitive Impairment With Benzodiazepine Use in the U.S.: An Analysis of Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • HPR87 Comparing Predicted vs. Real-World Spending in the United States for Single-Administration Cell and Gene Therapies

    Jul 1, 2025, 00:00

  • MSR85 Navigating Scarcity: Leveraging AI to Address the Challenges of Identifying Rare Disease Key Opinion Leaders

    Jul 1, 2025, 00:00

  • EE423 Treatment Patterns, Clinical Outcomes, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Metastatic Gastric/Gastroesophageal Junction Cancer in Medicare Beneficiaries

    Jul 1, 2025, 00:00

  • PCR37 The Impact of Out-of-Pocket Costs on Adherence Amongst US Oncology Patients on Oral Anticancer Medications

    Jul 1, 2025, 00:00

  • EE446 The Blinded Economic Impact of Chemotherapy: How Adverse Effects Affect Costs During Bladder Oncology Treatments

    Jul 1, 2025, 00:00

  • PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

    Jul 1, 2025, 00:00

  • PCR242 The Economic Burden of Narcolepsy in the United States: Matched Analysis of National Health and Wellness Survey Data

    Jul 1, 2025, 00:00

  • SA1 Open-Source LLMs Performance on Information Retrieval Tasks for Health Outcomes Research

    Jul 1, 2025, 00:00

  • MSR152 A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review

    Jul 1, 2025, 00:00

  • MSR111 Assessing the Accuracy of Artificial Intelligence in Conducting Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • EPH165 Race, Social Determinants of Health (SDoH), and Stage at Breast Cancer Diagnosis in Electronic Health Records (EHR) Data

    Jul 1, 2025, 00:00

  • HPR30 Advancing Real World Eviden Comparative Insights into Global Practices and China's Strategic Progress

    Jul 1, 2025, 00:00

  • MSR103 Regularized MAIC As a Modern Solution for Indirect Treatment Comparison Challenges

    Jul 1, 2025, 00:00

  • PCR51 Information-Seeking Behavior of the Hungarian Population Regarding Lung Cancer: A Digital Epidemiological Study Using Google Trends™

    Jul 1, 2025, 00:00

  • EPH170 Administrative Frequency of Vitiligo and Clinical Characteristics in a Colombian HMO: A Real World Data Characterization From 2015 to 2023

    Jul 1, 2025, 00:00

  • PCR11 Clinical Trial Participant and Clinician Experience in a Phase 2 (US-only) Trial of MM120 for Generalized Anxiety Disorder

    Jul 1, 2025, 00:00

  • PCR86 Health utilities of patients with multidrug-resistant tuberculosis and its influencing factors: A cross-sectional study based on EQ-5D-5L in China

    Jul 1, 2025, 00:00

  • RWD67 Analysis of Disease Progression in 769 Patients With Dominant Alport Syndrome

    Jul 1, 2025, 00:00

  • RWD57 Linkage of Clinical Trial Data to Real-World Data (RWD) Sources: A Scoping Review

    Jul 1, 2025, 00:00

  • PCR100 Interventions to Improve Adherence and Persistence to Oral Medication: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HPR97 The Social Distribution of Quality Adjusted Life Expectancy (QALE) Among Deprivation Subgroups in China

    Jul 1, 2025, 00:00

  • CO9 Exploring Patient Perspectives of Statistically Derived Item Weights for Composite Scores in Spinocerebellar Ataxia

    Jul 1, 2025, 00:00

  • EE361 Treatment Patterns and Efficacy/Safety of the Drugs in HER2+ NSCLC: A Systemic Literature Review

    Jul 1, 2025, 00:00

  • HTA4 The Use of QALYs in Decision-Making in Europe, Canada, and the US: A Qualitative Review of Methodological Guidance

    Jul 1, 2025, 00:00

  • RWD107 Analysis of Antibody-Drug Conjugate Usage in Patients Undergoing Circulating Tumor DNA Testing

    Jul 1, 2025, 00:00

  • MT1 Value of Personalized Refractive Procedure: A Survey of Perceived Clinical Outcomes, Practice Benefits, and Patient Satisfaction in China

    Jul 1, 2025, 00:00

  • PCR185 Associations Between Social Vulnerability and Long COVID: A Nationwide U.S. Study Among Symptomatic Outpatient

    Jul 1, 2025, 00:00

  • HPR155 Factors Responsible for Successful Value-Based Agreements and Barriers for Their Adoption in the United States

    Jul 1, 2025, 00:00

  • P54 Impact of Medicaid Enrollment Provisions on Postpartum Coverage and Resource Use in Three US States

    Jul 1, 2025, 00:00

  • EE514 Disease Burden Estimates in Economic Evaluation Studies of Respiratory Syncytial Virus (RSV) Maternal Immunization: A Systematic Review

    Jul 1, 2025, 00:00

  • EPH17 Time to Diagnosis of Lung Cancer From Identification of a Pulmonary Nodule in the United States

    Jul 1, 2025, 00:00

  • MSR89 Machine Learning Algorithms for Identifying Undiagnosed Nonalcoholic Steatohepatitis: A Veterans Affairs Health System Study

    Jul 1, 2025, 00:00

  • CO53 Comorbidity Burden Among Patients with Bullous Pemphigoid in the US Medicare Population

    Jul 1, 2025, 00:00

  • EE282 Quality-Adjusted Life Year (QALY) Results From a Cost-Effectiveness Model for Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Relapsed/Refractory Multiple Myeloma (RRMM)

    Jul 1, 2025, 00:00

  • EE419 Cost-Effectiveness Analysis of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Adults 60 Years of Age and Older in Japan

    Jul 1, 2025, 00:00

  • EE425 Economic Impact of Trastuzumab and Its Biosimilars for the Treatment of HER2-Positive Breast Cancer Patients: A Real-World Study in the US

    Jul 1, 2025, 00:00

  • EE460 Impact of Newborn Screening for Duchenne Muscular Dystrophy: A Model-Based Analysis

    Jul 1, 2025, 00:00

  • EE497 Cost-Effectiveness of Robot-Assisted and Laparoscopic Radical Nephrectomy Versus Open Radical Nephrectomy in the Treatment of Renal Cell Carcinoma

    Jul 1, 2025, 00:00

  • RWD65 Real-World Treatment Patterns, Patient Characteristics, Healthcare Resource Utilization and Costs for Intermediate Hepatocellular Carcinoma Patients in Canada: A Retrospective Cohort Study Using Provincial Administrative Data

    Jul 1, 2025, 00:00

  • EPH82 Association of Systemic Lupus Erythematosus and Psychosocial Outcomes: Analysis of a Nationally Representative Data, 2017-2022

    Jul 1, 2025, 00:00

  • EPH44 Changes in Outpatient Visits in a Medicaid Population in the Face of Physician Shortages

    Jul 1, 2025, 00:00

  • EE505 Economic Evaluation of Next-Generation Sequencing Technologies in Paediatric Patient Groups With Rare Diseases: a Systematic Review

    Jul 1, 2025, 00:00

  • PT25 The Impact of Financial Assistance Programs on Medication Adheren A Systematic Review With AI-Driven Prediction

    Jul 1, 2025, 00:00

  • CO31 Systematic Literature Review of Recombinant C1 Esterase Inhibitor (rhC1-INH) and Other Products for the On-Demand Treatment of Hereditary Angioedema Attacks

    Jul 1, 2025, 00:00

  • HPR16 Emerging Trends in List Price Adjustment Strategies Following Implementation of the Inflation Reduction Act

    Jul 1, 2025, 00:00

  • HPR2 Mapping Disparities in Clinical Trial Enrollment Among HCC Patients: Insights From Social Determinants of Health

    Jul 1, 2025, 00:00

  • RWD52 Treatment Patterns for Sleep Disorders in the United States Veterans Affairs Healthcare System

    Jul 1, 2025, 00:00

  • HTA30 Incorporating Caregiver Burden in Japans Cost-Effectiveness Evaluation: A Case Study of Teduglutide for Pediatric Short Bowel Syndrome

    Jul 1, 2025, 00:00

  • MT14 Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review

    Jul 1, 2025, 00:00

  • CO20 Real-World Overall Survival of Multiple Myeloma Patients in a Colombian HMO During 2015-2023

    Jul 1, 2025, 00:00

  • MSR107 MetaSLR in Automating the Data Collection for Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • PCR250 Burden of COVID-19 on Health-Related Quality of Life in Immunocompromised Adult Participants From the EPIC-IC Trial

    Jul 1, 2025, 00:00

  • EE473 Cost-Efficiency Modeling of Conversion to Biosimilar Rituximab-pvvr in Diffuse Large B-Cell Lymphoma in Medicare

    Jul 1, 2025, 00:00

  • RWD77 Patterns in Provider Specialties and Adoption of Non-Invasive Tests (NITs) for Diagnosing Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Jul 1, 2025, 00:00

  • RWD11 Real-World Unmet Needs in Patients With HER2-Negative Advanced Gastric, Gastro-Esophageal or Esophageal Adenocarcinoma Receiving First-Line Treatment Globally

    Jul 1, 2025, 00:00

  • CO65 Real-world Impact of Semaglutide, Liraglutide, and Tirzepatide on Weight Loss and Cardiometabolic Lab Measures: A Look into Drug Persistence and Reasons for Discontinuation (r/dc)

    Jul 1, 2025, 00:00

  • EE399 Economic Impact of Immunobiological Therapies in Disease Affecting Skin from the Perspective of Population Health Management in LMIC/LATAM/Brazil

    Jul 1, 2025, 00:00

  • RWD23 Unlocking the Potential of Radiology Reports Using NLP: A Real-World Data Approach to Rotator Cuff Tear Severity

    Jul 1, 2025, 00:00

  • EPH53 Analysis of the Contribution of Air Pollution and Noise Levels to Predicting Autonomic Nervous System Disorders: An Interpretable Machine Learning Approach

    Jul 1, 2025, 00:00

  • EPH27 Health and Economic Value of Pneumococcal Conjugate Vaccine Against Antimicrobial Resistance in Brazil: An Agent-based Simulation Study

    Jul 1, 2025, 00:00

  • EE509 Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel

    Jul 1, 2025, 00:00

  • MSR66 Developing a Risk Prediction Model for the Identification of Necrotizing Fasciitis (NF) in Patients

    Jul 1, 2025, 00:00

  • PCR212 Development and Psychometric Validation of Patient-Reported Outcome Measures for Masseter Muscle Prominence (MMP): The Lower Facial Shape Questionnaire

    Jul 1, 2025, 00:00

  • HSD14 Colorectal Cancer Screening Initiation Modalities Among Newly Age-Eligible Medicaid-Insured Individuals in Texas

    Jul 1, 2025, 00:00

  • EPH69 Racial and Ethnic Disparities in Healthcare Expenditures Among United States Older Adults with Joint Pain

    Jul 1, 2025, 00:00

  • HPR75 Is the IRA Drug Price Negotiation an Evidence-Based Practice? A Critical Analysis of the Evidence Reviewed by CMS for IRA Drug Price Negotiations and Implications for Future Submissions

    Jul 1, 2025, 00:00

  • PCR223 Lifestyle Habits of Patients with Prediabetes Before and After Diagnosis

    Jul 1, 2025, 00:00

  • CO13 Dupilumab Improves Health-Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: Results From the BOREAS and NOTUS Trials

    Jul 1, 2025, 00:00

  • HSD36 Self-reported CAHPS Quality Measures by Medicare Beneficiary Social Vulnerability Index

    Jul 1, 2025, 00:00

  • HTA68 Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access

    Jul 1, 2025, 00:00

  • MSR137 A Statistical Method for Quality Assessment of Demographic Variables in EHR Data

    Jul 1, 2025, 00:00

  • MSR52 Tailoring Generalized Cost-Effectiveness Analysis (GCEA) to the U.S. Setting: the Importance of Using the Right Prices

    Jul 1, 2025, 00:00

  • EE421 Healthcare Cost Comparison Between 1L Ibrutinib and Acalabrutinib in Chronic Lymphocytic Leukemia Patients in the Veterans Affairs Population

    Jul 1, 2025, 00:00

  • RWD90 Analysis and Management of Computable Operational Definition (CODef) Concept Variation Based on a Large Real-World Studies Library

    Jul 1, 2025, 00:00

  • RWD136 Integration of Survival Analysis Outputs Into Excel-Based Cost-Effectiveness Models Using Generative AI

    Jul 1, 2025, 00:00

  • RWD147 The Role of Social Determinants of Health (SDoH) Data in Improving Risk Predictions

    Jul 1, 2025, 00:00

  • MSR53 Development and Validation of an LLM-Based Study Selection Tool for Automating Systematic Literature Reviews: Achieving Time Efficiency and Maintaining Gold Standard Accuracy

    Jul 1, 2025, 00:00

  • SA14 Economic Systematic Literature of Nirmatrelvir+Ritonavir for the Treatment of Patients With Mild to Moderate COVID-19

    Jul 1, 2025, 00:00

  • HPR85 The Duration of Medically Necessary Drug Shortages

    Jul 1, 2025, 00:00

  • CO52 Glucocorticoid Exposure and the Risk of Serious Infections in CIDP

    Jul 1, 2025, 00:00

  • HPR21 Association between Socioeconomic Factors and Guideline-Directed Medical Therapy (GDMT) Utilization Among Medicare Beneficiaries with Heart Failure with Reduced Ejection Fraction (HFrEF)

    Jul 1, 2025, 00:00

  • HPR14 A Different Approach to the Overall Survival Conversation: A Bayesian Analysis of Overall Survival Benefits Among Oncology Accelerated Approvals

    Jul 1, 2025, 00:00

  • EE239 Value of Liquid Biopsy for Genomic Profiling in Non-Small Cell Lung Cancer in Fran A Pharmacoeconomic Model

    Jul 1, 2025, 00:00

  • MSR6 Staffing Resource Use: A Cost Impact Model for the Utilization and Implementation of Medications for Opioid Use Disorder Within US Jails And Prisons

    Jul 1, 2025, 00:00

  • EE364 Economic Evaluation of Single-Inhaler Extrafine Beclometasone Dipropionate/formoterol fumarate/glycopyrronium (Trimbow®) in Adult Patients with Uncontrolled Asthma in Mexico

    Jul 1, 2025, 00:00

  • PCR214 Correlation and Predictors of EORTC QLQ-C30 GHS-QoL and EQ-5D VAS in Patients With Advanced NSCLC

    Jul 1, 2025, 00:00

  • EE492 Association Between Elevations in Alkaline Phosphatase and Healthcare Utilization and Costs Among Individuals With Primary Biliary Cholangitis In The United States

    Jul 1, 2025, 00:00

  • EPH192 The Trajectory of Ground Glass Nodule Patients in China: A Real-World Perspective

    Jul 1, 2025, 00:00

  • MT35 Race and Ethnicity Differences in the HPV Vaccine Initiation Prompted by Electronic Reminders

    Jul 1, 2025, 00:00

  • EPH168 Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses

    Jul 1, 2025, 00:00

  • CO64 Discordance Between Apolipoprotein B (apoB) and LDL-Cholesterol (LDL-C) and Incident Hypertension Risk among Patients with and without Type 2 Diabetes (T2D): An Analysis of US Real-World Data

    Jul 1, 2025, 00:00

  • EE325 A Systematic Literature Review of the Economic Burden in Patients with Ehlers-Danlos Syndrome in the United States

    Jul 1, 2025, 00:00

  • HSD47 Increase in Healthcare Professionals' Willingness to Counsel HPV Vaccine Hesitant Parents Post-Pandemic: Results from a National Survey

    Jul 1, 2025, 00:00

  • HTA27 How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?

    Jul 1, 2025, 00:00

  • EPH140 Analysis of the Epidemiological Burden of Osteoarthritis in Hungary Based on Data From the Global Burden of Disease Study

    Jul 1, 2025, 00:00

  • PCR103 Attitude, Knowledge, and Intention to Receive Shingles Vaccine Using the Theory of Planned Behavior in Saudi Arabia

    Jul 1, 2025, 00:00

  • EE350 Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada

    Jul 1, 2025, 00:00

  • PCR16 Integrating Patient-Reported Outcomes in Clinical Care: Opportunities and Roadblocks from the Clinician Perspective: A Scoping Review

    Jul 1, 2025, 00:00

  • Stakeholder Views on the Use and Challenges of Using Early Economic Evaluations in Health Innovation Development in The Netherlands

    Jul 1, 2025, 00:00

  • EPH160 Prevalence of Mental Health Conditions Among Individuals With Sickle Cell Disease in Texas Medicaid

    Jul 1, 2025, 00:00

  • CO48 Analyzing the Association Between Statin Use and New Onset Diabetes in the US: A Retrospective Analysis Using Integrated EHR and Claims Data

    Jul 1, 2025, 00:00

  • HPR6 Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years

    Jul 1, 2025, 00:00

  • EPH189 A Retrospective Claims Study Characterizing the Association Between RSV Infection and Acute Otitis Media and Related Burden in Infants and Young Children = 5 years in Japan

    Jul 1, 2025, 00:00

  • HTA57 Impact of China's NRDL Value-Rating System on Reimbursement and Pricing of Innovative Therapies

    Jul 1, 2025, 00:00

  • PCR75 Adverse Events: Does Experience Impact Preferences? A Review of the Literature

    Jul 1, 2025, 00:00

  • HPR84 Trends in Respiratory Pathogen Testing With Individual Pathogen, Small Panel, or Large Panel Polymerase Chain Reaction (PCR) Tests Before and After the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE) Ended

    Jul 1, 2025, 00:00

  • PCR48 An Overview of the Patient Journey and Treatment Utilization in Patients With Prurigo Nodularis

    Jul 1, 2025, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9 (current)
  • 10
  • »